The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival outcomes of adding stereotactic radiosurgery to dual immune checkpoint blockade in melanoma brain metastases: A systematic review and meta-analysis.
 
Arturo Ortiz
No Relationships to Disclose
 
Brenda Santellano
No Relationships to Disclose
 
Luis Cueva
No Relationships to Disclose
 
Marí­a Fernanda Gutiérrez Aguilera
No Relationships to Disclose
 
Andrea Iturralde-Carrillo
No Relationships to Disclose
 
Diana Laura Ochoa Hernandez
No Relationships to Disclose
 
Jeannina Rea Bucay
No Relationships to Disclose
 
Alan Mauricio Soli­s Velazquez
No Relationships to Disclose
 
Ailyne Naomi Flores Moreno
No Relationships to Disclose
 
Ana Camila Pech Castillo
No Relationships to Disclose
 
Sergio Gianfranco Luis Campos
No Relationships to Disclose
 
Lysette Allende García
No Relationships to Disclose
 
Maria del Consuelo Grimaldo Contreras
No Relationships to Disclose
 
Beatriz Aurora Gutierrez Rojas
No Relationships to Disclose
 
Diana Salas Lopez
No Relationships to Disclose
 
Isaac Arturo Díaz Chapol
No Relationships to Disclose
 
Leslie Morales Alvarez
No Relationships to Disclose
 
Kendall Buchanan
No Relationships to Disclose
 
Jorge Cortes
Consulting or Advisory Role - Ascentage Pharma; Bio-Path Holdings, Inc; Enliven Therapeutics; Lilly; Novartis; Pfizer; Rigel; Sun Pharma; Syndax; Takeda; Terns Pharmaceuticals
Research Funding - Abbvie/Genentech (Inst); Ascentage Pharma (Inst); Bio-Path Holdings, Inc (Inst); Cyto Agents (Inst); Kuro Oncology (Inst); Novartis (Inst); Sun Pharma (Inst)